Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 140

1.

Serial optical coherence tomography-based observation of strut coverage on drug-eluting stent crossing side-branch vessels.

Lee SY, Kim JS, Shin DH, Kim BK, Ko YG, Choi D, Jang Y, Hong MK.

J Invasive Cardiol. 2012 Nov;24(11):569-73.

PMID:
23117310
[PubMed - indexed for MEDLINE]
Free Article
2.

Neointimal coverage on drug-eluting stent struts crossing side-branch vessels using optical coherence tomography.

Her AY, Lee BK, Shim JM, Kim JS, Kim BK, Ko YG, Choi D, Jang Y, Hong MK.

Am J Cardiol. 2010 Jun 1;105(11):1565-9. doi: 10.1016/j.amjcard.2010.01.013. Epub 2010 Apr 10.

PMID:
20494663
[PubMed - indexed for MEDLINE]
3.

Quantitative and qualitative changes in DES-related neointimal tissue based on serial OCT.

Kim JS, Hong MK, Shin DH, Kim BK, Ko YG, Choi D, Jang Y.

JACC Cardiovasc Imaging. 2012 Nov;5(11):1147-55. doi: 10.1016/j.jcmg.2012.01.024.

PMID:
23153915
[PubMed - indexed for MEDLINE]
Free Article
4.

Comparison of early strut coverage between zotarolimus- and everolimus-eluting stents using optical coherence tomography.

Kim S, Kim JS, Shin DH, Kim BK, Ko YG, Choi D, Cho YK, Nam CW, Hur SH, Jang Y, Hong MK.

Am J Cardiol. 2013 Jan 1;111(1):1-5. doi: 10.1016/j.amjcard.2012.08.037. Epub 2012 Oct 2.

PMID:
23040589
[PubMed - indexed for MEDLINE]
5.

Optical coherence tomographic comparison of neointimal coverage between sirolimus- and resolute zotarolimus-eluting stents at 9 months after stent implantation.

Kim JS, Kim JS, Shin DH, Kim BK, Ko YG, Choi D, Jang Y, Hong MK.

Int J Cardiovasc Imaging. 2012 Aug;28(6):1281-7. doi: 10.1007/s10554-011-9943-x. Epub 2011 Aug 21.

PMID:
21858655
[PubMed - indexed for MEDLINE]
6.

Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents.

Guagliumi G, Musumeci G, Sirbu V, Bezerra HG, Suzuki N, Fiocca L, Matiashvili A, Lortkipanidze N, Trivisonno A, Valsecchi O, Biondi-Zoccai G, Costa MA; ODESSA Trial Investigators.

JACC Cardiovasc Interv. 2010 May;3(5):531-9. doi: 10.1016/j.jcin.2010.02.008.

PMID:
20488410
[PubMed - indexed for MEDLINE]
Free Article
7.

Initial findings of impact of strut width on stent coverage and apposition of sirolimus-eluting stents assessed by optical coherence tomography.

Nakatani S, Nishino M, Taniike M, Makino N, Kato H, Egami Y, Shutta R, Tanouchi J, Yamada Y.

Catheter Cardiovasc Interv. 2013 Apr;81(5):776-81. doi: 10.1002/ccd.24401. Epub 2012 May 24.

PMID:
22517601
[PubMed - indexed for MEDLINE]
8.

Evaluation of long-term follow-up with neointimal coverage and stent apposition after sirolimus-eluting stent implantation by optical coherence tomography.

Li S, Gai L, Yang T, Zhang L, Xu X, Bai Q, Xu H, Wang Y.

Catheter Cardiovasc Interv. 2013 Apr;81(5):768-75. doi: 10.1002/ccd.24497. Epub 2012 Jul 23.

PMID:
22639418
[PubMed - indexed for MEDLINE]
9.

Optical coherence tomography-based evaluation of malapposed strut coverage after drug-eluting stent implantation.

Kim BK, Shin DH, Kim JS, Ko YG, Choi D, Jang Y, Hong MK.

Int J Cardiovasc Imaging. 2012 Dec;28(8):1887-94. doi: 10.1007/s10554-012-0039-z. Epub 2012 Mar 25.

PMID:
22447206
[PubMed - indexed for MEDLINE]
10.

Different vascular healing patterns with various drug-eluting stents in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: optical coherence tomographic findings.

Fan C, Kim JS, Lee JM, Kim TH, Park SM, Wi J, Paik SI, Ko YG, Choi D, Hong MK, Jang Y.

Am J Cardiol. 2010 Apr 1;105(7):972-6. doi: 10.1016/j.amjcard.2009.11.018. Epub 2010 Feb 13.

PMID:
20346315
[PubMed - indexed for MEDLINE]
11.

Evaluation of neointimal coverage and apposition with various drug-eluting stents over 12 months after implantation by optical coherence tomography.

Li S, Wang Y, Gai L, Yang T, Liu H, Wang Z, Bai Q, Xu X, Chen Y.

Int J Cardiol. 2013 Jan 20;162(3):166-71. doi: 10.1016/j.ijcard.2011.05.076. Epub 2011 Jun 8.

PMID:
21641053
[PubMed - indexed for MEDLINE]
12.

Favorable neointimal coverage in everolimus-eluting stent at 9 months after stent implantation: comparison with sirolimus-eluting stent using optical coherence tomography.

Choi HH, Kim JS, Yoon DH, Hong KS, Kim TH, Kim BK, Ko YG, Choi D, Jang Y, Hong MK.

Int J Cardiovasc Imaging. 2012 Mar;28(3):491-7. doi: 10.1007/s10554-011-9849-7. Epub 2011 Mar 26.

PMID:
21442265
[PubMed - indexed for MEDLINE]
13.

Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.

Fujino Y, Attizzani GF, Bezerra HG, Wang W, Tahara S, Yamamoto H, Chamie D, Kanaya T, Mehanna E, Takagi K, Nakamura S, Costa MA.

JACC Cardiovasc Interv. 2013 Oct;6(10):1035-45. doi: 10.1016/j.jcin.2013.05.015.

PMID:
24156964
[PubMed - indexed for MEDLINE]
14.

Long-term (≥2 years) follow-up optical coherence tomographic study after sirolimus- and paclitaxel-eluting stent implantation: comparison to 9-month follow-up results.

Kim TH, Kim JS, Kim BK, Ko YG, Choi D, Jang Y, Hong MK.

Int J Cardiovasc Imaging. 2011 Jul;27(6):875-81. doi: 10.1007/s10554-010-9729-6. Epub 2010 Oct 27.

PMID:
20978851
[PubMed - indexed for MEDLINE]
15.

Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial.

Kim JS, Jang IK, Fan C, Kim TH, Kim JS, Park SM, Choi EY, Lee SH, Ko YG, Choi D, Hong MK, Jang Y.

JACC Cardiovasc Interv. 2009 Dec;2(12):1240-7. doi: 10.1016/j.jcin.2009.10.006.

PMID:
20129551
[PubMed - indexed for MEDLINE]
Free Article
16.

Comparison of neointimal coverage of sirolimus-eluting stents and paclitaxel-eluting stents using optical coherence tomography at 9 months after implantation.

Kim JS, Kim JS, Kim TH, Fan C, Lee JM, Kim W, Ko YG, Choi D, Hong MK, Jang Y.

Circ J. 2010 Feb;74(2):320-6. Epub 2009 Dec 17.

PMID:
20019414
[PubMed - indexed for MEDLINE]
Free Article
17.

Stent strut coverage of titanium-nitride-oxide coated stent compared to paclitaxel-eluting stent in acute myocardial infarction: TITAX-OCT study.

Lehtinen T, Airaksinen KE, Ylitalo A, Karjalainen PP.

Int J Cardiovasc Imaging. 2012 Dec;28(8):1859-66. doi: 10.1007/s10554-012-0032-6. Epub 2012 Feb 24.

PMID:
22362097
[PubMed - indexed for MEDLINE]
18.

Assessment by optical coherence tomography of stent struts across side branch. -Comparison of bare-metal stents and drug-elution stents.-.

Liu Y, Imanishi T, Kubo T, Tanaka A, Kitabata H, Tanimoto T, Ino Y, Ikejima H, Tsujioka H, Komukai K, Ishibashi K, Kashiwagi M, Ozaki Y, Hirata K, Mizukoshi M, Akasaka T.

Circ J. 2011;75(1):106-12. Epub 2010 Oct 28.

PMID:
21041972
[PubMed - indexed for MEDLINE]
Free Article
19.

Comparison of zotarolimus-eluting stent and everolimus-eluting stent for vascular healing response: serial 3-month and 12-month optical coherence tomography study.

Kim SJ, Lee H, Cho JM, Park CB, Kim W, Kato K, Yonetsu T, Kim CJ, Jang IK.

Coron Artery Dis. 2013 Aug;24(5):431-9. doi: 10.1097/MCA.0b013e328362b2e7.

PMID:
23722649
[PubMed - indexed for MEDLINE]
20.

Neointimal coverage and stent strut apposition six months after implantation of a paclitaxel eluting stent in acute coronary syndromes: an optical coherence tomography study.

Davlouros PA, Nikokiris G, Karantalis V, Mavronasiou E, Xanthopoulou I, Damelou A, Tsigkas G, Alexopoulos D.

Int J Cardiol. 2011 Sep 1;151(2):155-9. doi: 10.1016/j.ijcard.2010.05.004. Epub 2010 Jun 3.

PMID:
20605242
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk